(1998) found that MK-677 helped increase GH levels and preserve levels of fat-free mass (FFM) when administered to twenty-four obese males while dieting
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA et al
Using a lower dose of medication will slow weight loss, but it may cause fewer cosmetic side effects
There is no built-in coaching or lifestyle program, and long-term data is still limited, though plans are in place to expand into structured nutrition and metabolic support
It may be a therapy platform that simultaneously addresses obesity, diabetes, cardiovascular risk, and metabolic dysfunction